Dr. Robert Stein, MD, PhD, Named CEO of KineMed, Inc.

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, Inc., announced today the appointment of Robert Stein, MD, PhD, as Chief Executive Officer of the Company, effective August 1, 2008, and Member of its Board of Directors. KineMed is a leader in translational medicine-based drug development. Its business model is to acquire and advance drugs to treat atherosclerosis by enhancing the body’s process of removing cholesterol from tissues and from the body.

MORE ON THIS TOPIC